����Ӱҵ

Tuesday, April 23, 2024

����Ӱҵ to increase pay levels for pre- and postdoctoral scholars at grantee institutions

The ����Ӱҵ (����Ӱҵ) will increase annual pay levels for predoctoral and postdoctoral scholars at ����Ӱҵ-funded external institutions who are recipients of the . Predoctoral scholars will receive an approximate 4% increase in their pay level bringing it to $28,224, and postdoctoral scholars will receive an approximate increase of 8%, with pay levels beginning at $61,008 and upwardly adjusted based on years of experience. ����Ӱҵ aims to increase these pay levels over the next five years. Eligible recipients also will receive a $500 increase in subsidies for childcare and an additional $200 for training-related expenses. The updated fiscal year 2024 pay levels are informed by from the ����Ӱҵ Advisory Committee to the Director to better attract and retain postdoctoral scholars. The new NRSA pay levels incorporate the largest year-over-year update since 2017.

“I have accepted the recommendations of the report on this important issue that was provided by my advisory group. ����Ӱҵ and our grantee institutions must invest in pre- and postdoctoral scholars to ensure the future of the biomedical research workforce and enterprise remains strong and globally competitive,” said ����Ӱҵ Director Monica M. Bertagnolli, M.D. “This revision of pay levels for NRSA recipients is just a first step toward reaffirming their value and ensuring they are appropriately compensated, and I am hopeful these continued efforts help us attract and retain our nation’s brightest scientific minds.”

While the amended pay levels do not reach the full funding increase recommended by the advisory group, ����Ӱҵ selected the current plan to allow for an immediate pay increase without drastic cuts to the number of available NRSA awards, though a small reduction in the number of positions is expected. The increase is based on current ����Ӱҵ funding levels, which remained flat in the constrained budget environment. Pending the availability of funds through future appropriations, ����Ӱҵ plans to further increase stipend funding levels over the next three to five years to reach the advisory group’s recommended starting pay level of $70,000 annually for postdoctoral NRSAs. Additionally, ����Ӱҵ-funded institutions may supplement NRSA recipients’ new pay levels with additional, non-����Ӱҵ funds and/or benefits.

“����Ӱҵ is committed to improving the experience of postdoctoral scholars and helping them thrive in a competitive biomedical research environment,” said Mike Lauer, M.D., ����Ӱҵ deputy director of extramural research. “I believe implementation of these recommendations will go far in giving these scholars the sense of job security and career prospects that will lead to long careers in biomedical research.”

The pay-level increase was informed by recommendations of ����Ӱҵ’s (ACD). Those recommendations were based on from the research community and a report from the ACD convened. The working group was charged with undertaking several evaluations to determine how best to build on current ����Ӱҵ efforts to improve the biomedical workforce. The ����Ӱҵ ACD provides input on a variety of matters pertinent to ����Ӱҵ’s responsibilities to conduct and support of biomedical research, medical science and biomedical communications.

About the ����Ӱҵ (����Ӱҵ): ����Ӱҵ, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. ����Ӱҵ is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about ����Ӱҵ and its programs, visit www.nih.gov.

����Ӱҵ…Turning Discovery Into Health^®